Navigation Links
Audet & Partners, LLP Files First Raptiva Lawsuit After Announced Withdrawal
Date:4/9/2009

Audet & Partners, LLP, a San Francisco, California-based trial law firm, filed the first complaint against Genentech arising out of the recently announced withdrawal of Raptiva medication. Filed in Alameda Superior Court, the complaint seeks general and punitive damages.

San Francisco, CA (PRWEB) April 9, 2009 -- Audet & Partners, LLP, a San Francisco, California-based trial law firm, filed the first complaint against Genentech arising out of the recently announced withdrawal of Raptiva medication. Filed in Alameda Superior Court (Case #rg09-446158), the complaint seeks general and punitive damages.

Raptiva is a medication used to treat severe to moderate psoriasis and works by suppressing the immune system. According to allegations in the complaint filed by Audet & Partners, LLP Raptiva allegedly causes a number of serious life-threatening infections, including encephalitis, viral meningitis and a rare brain infection known as progressive multifocal leukoencephalopathy (PML). At least three and possibly four cases of PML brain infections have been confirmed by the FDA.

Due to safety concerns, Raptiva already is suspended from the market in both Europe and Canada, and as of April 8, 2009, Genentech announced a phased withdrawal of Raptiva from the United States market.

"We have a number of clients who have contacted our firm over the past couple of months regarding Raptiva, and this is one of the first cases filed in the United States," noted William M. Audet, managing partner of Audet & Partners, LLP, "We expect that more cases will be filed by our firm as our investigation continues."

In the complaint, Plaintiff Mary Hedrick alleges that she suffered herpes viral encephalitis, a rare brain infection, as a result of being treated with Raptiva. This left her with permanent brain and nervous system damage requiring her to undergo intensive rehabilitation to relearn how to walk and speak. Plaintiff Shirley Boxell is suing on behalf of her daughter, Megan, who died of a brain infection at age 26, after taking Raptiva for one year. Plaintiff Bruce Harwell has suffered from severe leucopenia, as well as other injuries, allegedly due to Raptiva.

"All of the plaintiffs in this case have suffered serious injury while taking Raptiva, a monoclonal antibody that inhibits T-cell activity," stated Susanne Scovern, a trial attorney at Audet & Partners, LLP. "No one would choose to take a life-threatening drug for a non-life-threatening injury. The dangerous side effects of Raptiva far outweighed the good it did to treat psoriasis," she stated.

Audet & Partners, LLP, (221 Main Street, Suite 1460, San Francisco, CA 94105, 415.982.1776) a San Francisco-based law firm, represents individuals, governmental entities, small businesses and shareholders in product liability, tort, negligence, consumer, construction defect, investment fraud, securities, insider trading, antitrust, environmental, whistle blower, aviation and employment cases. The founding partner, William M. Audet, has served as court-approved lead counsel in dozens of federal and state cases throughout the United States.

# # #

Read the full story at http://www.prweb.com/releases/raptiva/lawsuit/prweb2315484.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Get Your Fruits & Veggies: CDC
2. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
3. Story ideas from molecular & cellular proteomics
4. Job picture for 2006 chemistry grads reasonably good, C&EN reports
5. Debut issue of Foot & Ankle Specialist
6. Congressional R&D Caucus co-chairs join scientists, engineers and graduate students
7. IU Health & Wellness: Research and insights from Indiana University
8. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
9. European Society of Human Reproduction & Embryology 24th annual meeting
10. IU Health & Wellness: New research findings from the Kinsey Institute
11. Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... with the American Society of Anesthesiologists® (ASA®), the Foundation for Anesthesia Education ... of Orthopaedic Surgeons (AAOS) and the Cigna Foundation, encourages proposals supporting high ...
(Date:1/23/2017)... ... ... “The Inn at the Mill”: a story of love and redemption, hope and uncertainty ... and content. , “The Inn at the Mill” is the creation of published author, ... and is now living in Berks County on Crow Hill. The inn, the ...
(Date:1/23/2017)... VA (PRWEB) , ... January ... ... Nutrition Partnership (SNP) has launched online education programs and resources at seafoodnutrition.org/programs ... and nutritional benefits of a seafood-rich diet. These resources have been developed ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Some Infallible Characteristics of Christ”: ... “Some Infallible Characteristics of Christ” is the creation of published author, Rev. Dr. Robert ... Church for thirteen years, a preacher for over nineteen, a pastor for over fifteen ...
(Date:1/22/2017)... ... January 22, 2017 , ... Phytocéane invites clients to take ... rest of the world with ZANZIBAR MILKY CREAM. Inspired by the beauty of Zanzibar, ... Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, velvety body cream ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... A new Transparency Market Research report states ... at US$0.53 bn in 2013 and is predicted to touch US$2.38 ... 2014 and 2022. The title of the report is "Non-invasive Prenatal ... Trends and Forecast 2014 - 2022." ... Non-invasive prenatal testing (NIPT), also referred to as ...
(Date:1/23/2017)... Longer life expectancy and rising healthcare expenditure in ... medical device technologies. BCC Research reveals in its new report ... region, should see strong growth due to rising government healthcare spending, ... Continue Reading ... ...
(Date:1/23/2017)... January 23, 2017 The global  anxiety disorders and depression ... 2025. The rising incidence of depression worldwide is anticipated to drive the market ... in the declining demand for antidepressants in the recent years. ... ... View Research Logo ...
Breaking Medicine Technology: